Updates to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection
The Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV (the Panel) has reviewed and updated the text and references of previous versions of the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection published on April 11, 2022, and October 11, 2022. Updates were made to the following sections:
When to Start
Clinical and Laboratory Monitoring of Pediatric HIV Infection
What Not to Start: Regimens Not Recommended for Use Antiretroviral-Naive Children
Special Considerations for Antiretroviral Therapy Use in Adolescents with HIV
Adherence to Antiretroviral Therapy in Children and Adolescents with HIV
Management of Medication Toxicity or Intolerance
Management of Children Receiving Antiretroviral Therapy
Appendix A: Pediatric Antiretroviral Drug Information
Save the Date: Ending the HIV Epidemic Quarterly Stakeholder Webinar
Wednesday, May 3, 2023
10:00-11:30 AM PT/ 1:00-2:30 PM ET
*This session will be audio recorded & slides will be available for those unable to attend*
Summary
Ending the HIV Epidemic in the U.S. (EHE), is a bold national plan that aims to reduce the number of new HIV transmissions in the United States.
Audience
This public-facing webinar will deliver information surrounding innovative housing solutions information to:
Federal staff whose agencies/programs/offices are engaged in implementing the Ending the HIV Epidemic in the U.S. initiative.
Funded recipients, sub-recipients, and health care workers that qualify as EHE jurisdictions.
Public health and health care service providers including but not limited to local health departments, community-based organizations, sexually transmitted infection clinics, community health centers, Title X clinics, and substance use disorder treatment providers who want to learn more about the EHE initiative.
Objectives
The United States Department of Health and Human Services, Office of the Assistant Secretary of Health will host the Ending the HIV Epidemic Initiative stakeholder webinar designed to:
Highlight innovative methods of housing collaborations
Highlight ways to improve HIV diagnosis, care, and prevention outcomes for individuals living with HIV
Provide an opportunity for questions and answers from major community members and government officials
Sample Social Post
Don’t miss out on the May 3rd #EndHIVEpidemic webinar! Join us from 1-2:30 P.M. ET
to hear from @HHSGov‘s OIDP, HUD, ONAP, and community leaders as they discuss current activities,
upcoming efforts and highlight innovative methods of housing collaborations. Visit here to register!
Registering:
Registration is required and limited so please register early!
For more information about Ending the HIV Epidemic in the U.S., visit HIV.gov.
Office of AIDS Stakeholder | Quarterly ADAP and PrEP-AP Learning Collaborative
Want to know more about the Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) Temporary Coverage and Immediate Access? Join the next CDPH Office of AIDS learning collaborative session!
The virtual session is on May 5th, 2023 from 10:30A.M. – 12:00P.M. PST. They will be providing an overview of the Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) Temporary Coverage and Immediate Access. Please register below to receive Zoom details!
Tuesday, April 18 is National Transgender HIV Testing Day (NTHTD), an observance designed to recognize the importance of routine HIV testing, status awareness and continued focus on HIV prevention and treatment efforts among transgender people. Transgender women are at high risk of having HIV and of contracting HIV.
In the United States, it is estimated that around 1.4 million adults identify as transgender. Transgender women are at high risk of having HIV and of contracting HIV. Transgender women of color, especially black/African American and Hispanic/Latina women, experience disproportionately high rates of HIV. There is a gap in research on HIV and transgender men; few studies have gathered HIV prevalence data for this population.
Access a toolkit from the Transgender Center of Excellence of below:
National Transgender HIV Testing Day (NTHTD) is observed each year on April 18. It recognizes the importance of routine HIV testing, status awareness, and continued focus on HIV prevention and treatment efforts in people who are transgender or gender nonbinary. NTHTD was established in 2016 by the Centers for Disease Control and Prevention (CDC) and the University of California, San Francisco Transgender Center of Excellence.
In 2019, adult and adolescent transgender people composed 2% of new HIV diagnoses in the United States. Transgender people face many challenges in the prevention, testing, and treatment of HIV. HIV stigma may prevent transgender people from learning about their HIV status. For example, it was found that HIV stigma was associated with delaying regular HIV testing among some young transgender women. While many people taking HIV medicines are virally suppressed, skipping doses of HIV medicines can quickly change their viral loads. Transgender people also face challenges in maintaining viral suppression due to multiple missed doses of HIV treatment, missed medical appointments, HIV stigma, transphobic discrimination, and difficulty accessing other important health care services. Data show that 43% of transgender people with HIV missed at least one medical appointment in the past 12 months, delaying their viral suppression (HIV and Transgender People: Viral Suppression, CDC).
The National Institutes of Health (NIH) supports research to address factors that cause disparities in HIV prevention, incidence, and treatment among different populations, including transgender people. The Sexual & Gender Minority Research Office (SGMRO) conducts Health Research Regional Workshops, Listening Sessions, and the SGM Administrative Supplements Program. The work that SGMRO undertakes helps to enhance our understanding of the health disparities encountered by transgender individuals.
Browse the links on this page to learn more about this annual observance and to find related transgender-specific information on HIV and AIDS.
NIH Research Related to HIV and AIDS in Transgender and Nonbinary People
NIH Strategic Plan for HIV and HIV-Related Research (for fiscal years 2021—2025). Developed by the NIH Office of AIDS Research, the plan describes NIH research priorities to prevent, treat, and eventually cure HIV and AIDS. Key NIH research areas include investigating factors influencing inequalities in HIV testing, engagement, and health outcomes, as well as strategies to mitigate HIV-associated stigma and discrimination.
National Youth HIV & AIDS Awareness Day (NYHAAD) on April 10th is an opportunity to educate others about the impact of HIV and AIDS on young people. Education and testing are critical to ending HIV – especially for young people living with HIV, who are the least likely group to have a suppressed viral load. Read on to learn more.
The CDC reports that in 2018, youth aged 13 to 24 made up 21% of the 37,832 new HIV diagnoses in the United States (US) and dependent areas.
The CDC reports that young people living with HIV are the least likely of any age group to be retained in care and have a suppressed viral load. Advocates for Youth recognizes that addressing HIV in youth requires that young people have access to honest and inclusive information and tools they need to make informed decisions.
The CDC reports that 37 states have laws that criminalize HIV exposure.
In the US, more than 50% of those accused in reported HIV criminalization cases in 2020 were people of color, a larger proportion than people of color estimated to be living with HIV in the US. Alongside our capacity-building partners, Advocates for Youth, we call to an end of the criminalization of young people living with HIV.
Pacific AETC Resources on Youth and HIV
Don’t miss out on our on-demand session, Adapting HIV Service for Youth During COVID-19 and Beyond.
Learning Objectives:
Explore the landscape for youth access to HIV services, including sexual health education, prevention, and care
Discuss the barriers and facilitators for youth transitioning from adolescent to adult HIV care and services
Identify strategies for youth to assist with clinical engagement, specifically during the COVID-19 pandemic
Identify and brainstorm resources to support youth focused HIV program can implement to support continued access to services
Now What? Care, Monitoring, and Treatment Options for Breast/Chestfeeding Parents Living with HIV and Their Infants
Date and Time
April 18th, 2023
10am – 11:30am PT / 1pm – 2:30pm ET
Learning Objectives
List options for antiretroviral prophylaxis for breast/chestfed infants and appropriate scenarios in which to utilize them.
Understand common postpartum challenges for breast/chestfeeding parents with HIV and their babies and demonstrate how your clinical practice can support solutions.
Describe important aspects of team-based care for breast/chestfeeding parents with HIV and their babies.
Save the Date: Ending the HIV Epidemic Quarterly Stakeholder Webinar
Learn more about 
